Moderna is establishing manufacturing footholds in far-flung outposts including Australia, Kenya, Canada and the U.K. Now, the company is setting up a plant closer to home in Massachusetts. The ...
British-based researchers are hoping to reduce the costs of mRNA production by expanding the range of manufacturing techniques. A team has created and are testing a huge library of RNA-polymerases, ...
RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today launched NTx Services. This new service ...
TriLink BioTechnologies, a unit of Maravai LifeSciences, said it plans to expand its mRNA manufacturing operations to meet growing demand from late-stage drug developers. The new 32,000-square-foot ...
GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and formulation capabilities with the launch of a GMP-like mRNA manufacturing service, ...
- Co-Hosts Seminar with mRNA CDMO Kudo Bio to Demonstrate Linea IVT Capability for Rapid mRNA Manufacturing - STONY BROOK, NY / ACCESSWIRE / September 17, 2024 / Applied DNA Sciences, Inc.
The "mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...
Moderna has chosen Oxfordshire, England as the location for its U.K. Innovation and Technology Centre (MITC), which is expected to open in 2025. The pharma’s new mRNA manufacturing facility will be ...
Stay ahead in the booming mRNA market, projected to reach $63.28 billion by 2025, with the 3 rd mRNA Process Development & Manufacturing Summit 2025 - Europe’s premier industry-focused forum dedicated ...
BURLINGTON, Vt.--(BUSINESS WIRE)--Vernal Biosciences, an innovative mRNA and LNP Contract Development and Manufacturing Organization (“CDMO”) announced the completion of a $20MM funding round, led by ...
Collaboration will support Australia with direct access to rapid pandemic response capabilities “We are excited to expand our presence and continue our long-term collaboration with the Australian and ...
MAINZ, GERMANY, and SINGAPORE, November 14, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback